NCT00774085View on ClinicalTrials.gov

An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone

CompletedOBSERVATIONAL
Enrollment

408

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Schizophrenia
Interventions
OTHER

No intervention was given

Participants included patients treated with long-acting injectable risperidone (Risperdal Consta) in daily practice according to local label by the physicians

All Listed Sponsors
lead

Janssen Cilag N.V./S.A.

INDUSTRY

NCT00774085 - An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone | Biotech Hunter | Biotech Hunter